Company performance
Add to research
Current Price
as of Mar 13, 2025$1.20
P/E Ratio
N/A
Market Cap
$37.44M
Loading...
Description
Add to research
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Metrics
Add to research
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerATNM
- Price$1.2+4.35%
Trading Information
- Market cap$37.44M
- Float97.46%
- Average Daily Volume (1m)157,088
- Average Daily Volume (3m)227,533
- EPS-$1.40
Company
- Revenue$0.08M
- Rev growth (1yr)N/A
- Net income-$11.57M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$12.40M
- EV-$18.53M
- EV/Revenue-228.83
- P/EN/A
- P/S460.32
- P/B0.98
- Debt/Equity4.48
Documents
Add to research
SEC Filings
Factset Street Account
Factset